Antihypertensive drugs and inflammation in acute ischemic stroke as a predictor factor of future cardiovascular mortality.


Benbir G. , Ince B. , Kumral E., Ongen Z. , Kultursay H., Tokgozoglu L., ...Daha Fazla

Inflammation, cilt.35, ss.65-73, 2012 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 35 Konu: 1
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1007/s10753-010-9290-4
  • Dergi Adı: Inflammation
  • Sayfa Sayıları: ss.65-73

Özet

The beneficial effects of antihypertensive drugs in secondary stroke prevention could not be based on their effects on lowering hypertension only.In this prospective study, the status of blood pressure, treatment regimens, new atherothrombotic event, blood sampling for hs-CRP and fibrinogen were asked at initial visit, 6th, and 12th months in 226 patients with atherothrombotic stroke.Eighty-seven percent of patients had an antihypertensive regimen, but hypertension control was achieved in 34.1% of patients.Neither use of six different antihypertensive drug regimens nor the change in blood pressure levels showed any difference on new atherothrombotic events, outcomes or survival rates.On the other hand, the higher levels of hs-CRP at baseline were found to be associated with higher mortality rates(p = 0.020).Our findings emphasize the predictive role of inflammation in future cardiovascular mortality in patients with acute ischemic stroke, indicating that inflammatory mediators underlying the atherothrombotic process play a more important role than it is assumed.